Genmab and AbbVie Report Positive Results from EPCORE™ NHL-1 Trial for Epcoritamab in Relapsed/Refractory Follicular Lymphoma

Based on the topline results from the EPCORE™ NHL-1 clinical trial, Genmab and AbbVie will engage with global regulatory authorities to discuss nex...

June 28, 2023 | Wednesday | News
Oncodesign Services announce access to ImaginAb’s CD8 ImmunoPET™ technology

By using this cutting-edge imaging technology in preclinical studies, Oncodesign Services’ team hopes to gain insights of the predictive effectivenes...

June 28, 2023 | Wednesday | News
TLX250-CDx Shows Potential Utility in ccRCC Staging: New ZIRCON Phase III Data Presented in Australia.

New data demonstrates the ability of TLX250-CDx to detect extrarenal lesions, supporting potential clinical utility in the metastatic or recurrent setting,...

June 27, 2023 | Tuesday | News
Bristol Myers Squibb Gets European Commission Approval for CAMZYOS® in Treating Symptomatic Obstructive HCM

CAMZYOS is the first and only cardiac myosin inhibitor approved in the European Union Approval based on two positive Phase 3 trials, EXPLORER-HCM and VALO...

June 27, 2023 | Tuesday | News
ERYTECH and PHERECYDES announce merger and name change to PHAXIAM Therapeutics

Merger approved with large majority by the shareholders of both companies New governance structure implemented Ambition to create a global leader in ex...

June 27, 2023 | Tuesday | News
Bavarian Nordic to Supply Smallpox Vaccines for EU Strategic Reserve

The strategic stockpile has been established to enable rapid deployment to EU member states and other countries participating in the EU Civil Protection Me...

June 26, 2023 | Monday | News
South Korean SK pharmteco doubles viral vector production capacity in Europe

Yposkesi, SK pharmteco's clinical and commercial viral vector manufacturing subsidiary for Cell and Gene Therapy (C>), completes i...

June 23, 2023 | Friday | News
Cytiva launches 2023 Biopharma Resilience Index

Biopharma’s own leaders express a declining sense of industry resilience in the latest wide-reaching survey from Cytiva. The Global Biopharma Resilie...

June 22, 2023 | Thursday | Reports
Abcam Highlights Successful Execution of Strategic Priorities to Drive Shareholder Value

Under CEO Alan Hirzel’s leadership, Abcam has transformed as a business, created significant value for all stakeholders, and outperformed the m...

June 21, 2023 | Wednesday | News
Diatech Pharmacogenetics Announces New Collaboration to Advance Precision Testing in Oncology

Diatech Pharmacogenetics (“Diatech”) has established a collaboration agreement with Janssen Pharmaceutica NV with the aim of improving access t...

June 21, 2023 | Wednesday | News
Navidea Biopharmaceuticals, Inc. Gets $7.5M Cash from Cardinal Health Instead of Milestone Payment

Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) (“Navidea” or the “Company”), a company focused on the development of precis...

June 20, 2023 | Tuesday | News
QIAGEN provides reminder on settlement mechanics of 2023 and 2024 convertible notes

QIAGEN N.V.  announced  a notice (reiterating its notice to holders dated January 9, 2019) to holders of the following: - 0.500% Senior Unsecure...

June 19, 2023 | Monday | News
QIAGEN's QuantiFERON-TB Gold Plus Shows Unique Clinical Benefits in Tuberculosis Screenings

QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) welcomes the publication of a new systematic evaluation that underlines the unique benefits of the compa...

June 16, 2023 | Friday | News
ACROBiosystems Aneuro Teams Up with Diagnostic Biochips for Neuroscience Drug Discovery

Electrophysiology is a critical part of neuroscience research, especially when attempting to elucidate the neural network. Monitoring the brain's field pot...

June 14, 2023 | Wednesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close